PKI has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
PKI has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companyยs financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 0.182 |
PKI's Cash to Debt is ranked lower than
85% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 6.43 vs. PKI: 0.182 ) |
PKI'
s 10-Year Cash to Debt Range
Min: 0.15 Max: 2.06 Current: 0.18 |
| Equity to Asset | -0.183 |
PKI's Equity to Asset is ranked lower than
94% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 0.47 vs. PKI: -0.183 ) |
PKI'
s 10-Year Equity to Asset Range
Min: -0.24 Max: 0.09 Current: -0.18 |
| Interest Coverage | 2.2 |
PKI's Interest Coverage is ranked lower than
73% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 46.10 vs. PKI: 2.2 ) |
PKI'
s 10-Year Interest Coverage Range
Min: 2 Max: No Debt Current: 2.2 |
| F-Score: 6 |
|
| Z-Score: 2.33 |
|
| M-Score: -2.64 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
ยย3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rankย
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | 4.70 |
PKI's Operating margin (%) is ranked higher than
55% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 7.00 vs. PKI: 4.70 ) |
PKI'
s 10-Year Operating margin (%) Range
Min: 1.6 Max: 10.9 Current: 4.7 |
| Net-margin (%) | 3.3 |
PKI's Net-margin (%) is ranked higher than
60% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 3.30 vs. PKI: 3.3 ) |
PKI'
s 10-Year Net-margin (%) Range
Min: -10.1 Max: 22.5 Current: 3.3 |
| ROE (%) | 3.6 |
PKI's ROE (%) is ranked higher than
60% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.80 vs. PKI: 3.6 ) |
PKI'
s 10-Year ROE (%) Range
Min: -12.1 Max: 28 Current: 3.6 |
| ROA (%) | 1.8 |
PKI's ROA (%) is ranked higher than
54% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 2.40 vs. PKI: 1.8 ) |
PKI'
s 10-Year ROA (%) Range
Min: -5.4 Max: 12 Current: 1.8 |
| ROC (Joel Greenblatt) (%) | 22.80 |
PKI's ROC (Joel Greenblatt) (%) is ranked higher than
77% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 14.00 vs. PKI: 22.80 ) |
PKI'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 3.7 Max: 78.1 Current: 22.8 |
| Revenue Growth (%) | 4.3 |
PKI's Revenue Growth (%) is ranked higher than
53% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 4.40 vs. PKI: 4.3 ) |
PKI'
s 10-Year Revenue Growth (%) Range
Min: -8 Max: 9.8 Current: 4.3 |
| EBITDA Growth (%) | -1.1 |
PKI's EBITDA Growth (%) is ranked higher than
63% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.50 vs. PKI: -1.1 ) |
PKI'
s 10-Year EBITDA Growth (%) Range
Min: -15.7 Max: 20.4 Current: -1.1 |
| EPS Growth (%) | -4.4 |
PKI's EPS Growth (%) is ranked lower than
57% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: -2.15 vs. PKI: -4.4 ) |
PKI'
s 10-Year EPS Growth (%) Range
Min: -49.4 Max: 31.4 Current: -4.4 |
| Jim Simons 338,000 sh (+1382.46%) Ken Fisher 71,900 sh (+60.85%) Steven Cohen 409,445 sh (+27.02%) PRIMECAP Management 604,185 sh (+17.11%) Chuck Royce 4,746,710 sh (+3.59%) | Columbia Wanger 985,000 sh (unchged) | Joel Greenblatt Sold Out Mario Gabelli 19,900 sh (-11.16%) David Dreman 1,110,206 sh (-13.83%) |
| Paul Tudor Jones 450,000 sh (New) PRIMECAP Management 943,359 sh (+56.14%) Jim Simons 520,100 sh (+53.88%) Chuck Royce 4,809,510 sh (+1.32%) | Columbia Wanger 985,000 sh (unchged) Ken Fisher 71,900 sh (unchged) | David Dreman 1,080,182 sh (-2.7%) Mario Gabelli 18,900 sh (-5.03%) Steven Cohen 59,361 sh (-85.5%) |
| Bruce Kovner 66,000 sh (New) Columbia Wanger 1,555,000 sh (+57.87%) PRIMECAP Management 1,208,106 sh (+28.06%) Jim Simons 546,500 sh (+5.08%) | Ken Fisher 71,900 sh (unchged) | Mario Gabelli Sold Out Paul Tudor Jones Sold Out Chuck Royce 4,791,510 sh (-0.37%) David Dreman 878,390 sh (-18.68%) Steven Cohen 8,460 sh (-85.75%) |
| Paul Tudor Jones 232,000 sh (New) Meridian Funds 632,500 sh (New) Ray Dalio 51,497 sh (New) Steven Cohen 71,939 sh (+750.34%) Ken Fisher 312,980 sh (+335.3%) Jim Simons 1,006,400 sh (+84.15%) | Columbia Wanger 1,555,000 sh (unchged) | Bruce Kovner Sold Out David Dreman Sold Out PRIMECAP Management 1,195,400 sh (-1.05%) Chuck Royce 4,121,320 sh (-13.99%) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| David Dreman | 2013-03-31 | Sold Out | 0.8% | $31.74 - $35.86 | $ 32.19 | -6% | 0 | |
| Meridian Funds | 2013-03-31 | New Buy | 0.78% | $31.74 - $35.86 | $ 32.19 | -6% | 632500 | |
| Ken Fisher | 2013-03-31 | Add 335.3% | 0.02% | $31.74 - $35.86 | $ 32.19 | -6% | 312980 | |
| Ray Dalio | 2013-03-31 | New Buy | 0.02% | $31.74 - $35.86 | $ 32.19 | -6% | 51497 | |
| PRIMECAP Management | 2012-12-31 | Add 28.06% | 0.01% | $27.84 - $32.29 | $ 32.19 | 5% | 1208106 | |
| Mario Gabelli | 2012-12-31 | Sold Out | 0.004% | $27.84 - $32.29 | $ 32.19 | 5% | 0 | |
| PRIMECAP Management | 2012-09-30 | Add 56.14% | 0.02% | $23.88 - $30.36 | $ 32.19 | 20% | 943359 | |
| Joel Greenblatt | 2012-06-30 | Sold Out | 0.09% | $24.96 - $27.9 | $ 32.19 | 22% | 0 | |
| Ken Fisher | 2012-06-30 | Add 60.85% | $24.96 - $27.9 | $ 32.19 | 22% | 71900 |
More recent guru trades are included for Premium Members only!!| vs
industry |
vs
history |
||
|---|---|---|---|
| P/E(ttm) | 46.60 |
PKI's P/E(ttm) is ranked lower than
67% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 25.40 vs. PKI: 46.60 ) |
PKI'
s 10-Year P/E(ttm) Range
Min: 5.44 Max: 736.05 Current: 46.6 |
| P/B | 1.89 |
PKI's P/B is ranked higher than
65% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 2.41 vs. PKI: 1.89 ) |
PKI'
s 10-Year P/B Range
Min: 0.49 Max: 8.8 Current: 1.89 |
| P/S | 1.76 |
PKI's P/S is ranked higher than
60% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 2.40 vs. PKI: 1.76 ) |
PKI'
s 10-Year P/S Range
Min: 0.42 Max: 3.55 Current: 1.76 |
| PFCF | 37.43 |
PKI's PFCF is ranked higher than
59% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 23.35 vs. PKI: 37.43 ) |
PKI'
s 10-Year PFCF Range
Min: 7.78 Max: 4.82065E+17 Current: 37.43 |
| EV-to-EBIT | 45.69 |
PKI's EV-to-EBIT is ranked lower than
56% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 16.12 vs. PKI: 45.69 ) |
PKI'
s 10-Year EV-to-EBIT Range
Min: 9.4 Max: 622.5 Current: 45.69 |
| Shiller P/E | 25.37 |
PKI's Shiller P/E is ranked higher than
90% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 23.85 vs. PKI: 25.37 ) |
PKI'
s 10-Year Shiller P/E Range
Min: 3.52 Max: 41.76 Current: 25.37 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Dividend Yield | 0.87 |
PKI's Dividend Yield is ranked higher than
67% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.55 vs. PKI: 0.87 ) |
PKI'
s 10-Year Dividend Yield Range
Min: 0.48 Max: 6.02 Current: 0.87 |
| Dividend Payout | 0.5 |
PKI's Dividend Payout is ranked higher than
91% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 0.53 vs. PKI: 0.5 ) |
PKI'
s 10-Year Dividend Payout Range
Min: 0.09 Max: 4.17 Current: 0.5 |
| Yield on cost (5-Year) | 0.90 |
PKI's Yield on cost (5-Year) is ranked higher than
66% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 1.66 vs. PKI: 0.90 ) |
PKI'
s 10-Year Yield on cost (5-Year) Range
Min: 0.48 Max: 6.02 Current: 0.9 |
| Share Buyback Rate | 0.4 |
PKI's Share Buyback Rate is ranked higher than
90% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: -1.70 vs. PKI: 0.4 ) |
PKI'
s 10-Year Share Buyback Rate Range
Min: 2.5 Max: -7.7 Current: 0.4 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Net Current Asset Value | 8.1 |
PKI's Price/Net Current Asset Value is ranked higher than
50% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 12.40 vs. PKI: 8.1 ) |
PKI'
s 10-Year Price/Net Current Asset Value Range
Min: 3.2 Max: 14.5 Current: 8.1 |
| Price/DCF (Projected) | 1.2 | ||
| Price/Median PS Value | 1.1 |
PKI's Price/Median PS Value is ranked higher than
73% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 0.90 vs. PKI: 1.1 ) |
PKI'
s 10-Year Price/Median PS Value Range
Min: 0.5 Max: 2 Current: 1.1 |
| Earnings Yield (Greenblatt) | 2.20 |
PKI's Earnings Yield (Greenblatt) is ranked higher than
65% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 5.70 vs. PKI: 2.20 ) |
PKI'
s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2 Max: 10.6 Current: 2.2 |
| Forward Rate of Return (Yacktman) | 0.02 |
PKI's Forward Rate of Return (Yacktman) is ranked higher than
65% of the 124 Companies in the Global Medical Instruments & Supplies industry. ( Industry Median: 8.11 vs. PKI: 0.02 ) |
PKI'
s 10-Year Forward Rate of Return (Yacktman) Range
Min: -28.2 Max: 48.1 Current: 0.02 |
| Industry: | Medical Instruments & Supplies | |
|---|---|---|
| Compare: | WST, BAX, COV, TMO, COO | |
| Traded in other countries: | PKN.Germany |
| The Biggest Ex-Dividend Stocks of Oct. 17 Oct 16 2012 |
| The Best Dividends on April 18, 2012 Apr 18 2012 |
| PerkinElmer Inc. Reports Operating Results (10-K) Mar 01 2011 |
| PerkinElmer Inc. Reports Operating Results (10-Q) Nov 10 2010 |
| PerkinElmer Inc. Reports Operating Results (10-Q) Aug 10 2010 |
| PerkinElmer Inc. Reports Operating Results (10-Q) May 13 2010 |
| PerkinElmer Inc. (PKI) Chairman, President & CEO Robert F Friel sells 150,000 Shares Dec 17 2009 |
| PerkinElmer Inc. Reports Operating Results (10-Q) Aug 14 2009 |
| PerkinElmer Inc. Reports Operating Results (10-Q) May 15 2009 |